Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
aripiprazole, Quantity: 5 mg
Alembic Pharmaceuticals Australia Pty Ltd
Tablet, uncoated
Excipient Ingredients: lactose monohydrate; crospovidone; magnesium stearate; hyprolose; microcrystalline cellulose; maize starch; silicon dioxide; indigo carmine aluminium lake
Oral
30 tablets
(S4) Prescription Only Medicine
ALEMBIC Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.
Visual Identification: Blue colour, modified rectangular shaped, uncoated tablets debossed with 250 on one side and plain on other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2020-09-23